3
Participants
Start Date
September 11, 2020
Primary Completion Date
October 4, 2023
Study Completion Date
October 4, 2023
Buspirone
40mg
Levodopa-Carbidopa
400mg/100mg
Buspirone + Levodopa-Carbidopa
40mg + 400mg/100mg
Placebo oral tablet
Non-active metabolite
CHUV, Lausanne
Ecole Polytechnique Fédérale de Lausanne
OTHER
Centre Hospitalier Universitaire Vaudois
OTHER